Hypercalcemia presents difficult problems of diagnosis and therapy. Recent studies in adults and animal tumor models have established that prostaglandin excess can be etiologic. The resultant hypercalcemia is responsive to inhibitors of prostaglandin synthetase.
the normal range thereafter except during attempts to lower ASA dosage at 14 days. A similar effect was noted in a second infant with subcutaneous fat necrosis. Calcium fell only to 13 mgldl from 18, however, and diuretic therapy was successfully added. In both patients, elevated serum triglyceride levels also responded rapidly. A third infant with hypercalcemia, nephrocalcinosis and trisomy 21-22 mosaicism was treated. ASA rapidly lowered serum calcium to normal. ASA was discontinued after 13 days without exacerbation. Despite extensive clinical studies in each case, no definitive mechanism for hypercalcernia was found. These preliminary case studies suggest a role for prostaglandins in certain hypercalcemic states as well as a potentially safe form of therapy. The recent demonstration that glycosylated hemoglobin measure ments correlate with integrated blood glucose levels over the preceding 1 to 2 months and the mounting experimental evidence that maintenance of normal blood glucose levels may reduce diabetic complications, suggests that early vigorous treatment of newly diagnosed juvenile diabetics, monitored by Hb A1C measurements, may be important in the long-range managements of these children. Fifteen youngsters, ages 3 to 18, were studied at the time of diagnosis of insulin-dependent diabetes and sequentially at 1 to 2 months intervals. Initial concentrations of Hb AIC were 8.6+1.2% of total hemoglobin (normal, non-diabetic children 2.2-4.8%). indicating the presence of hyperglycemia for a significant period of time prior to diagnosis. Within 4 to 6 weeks after diagnosis and placement of the children on a therapeutic regimen designed to promote normoglycemia, Hb A1C values decline, to 5.4+0.9% and were maintained at these levels in 12 of the 15 patients for periods ranging up to one year. No significant hypoglycemic reactions occurred in any of the children on the "tight control" protocol which included high protein meals plus 3 snacks per day, daily afternoon exercise and a combination of intermediate and short acting insulin given once or twice per day. The results indicate that it is possible to maintain insulin dependent diabetic children in a relatively euglycemic state that can be monitored sequentially by Hb AIC determinadons GROWTH HORMONE GH MODULATION OF VITAMIN D METABOLISM. Yoief'Weisman. Gail box. Edward Reiter, and Allen Root. Dept. Ped., Univ. So. Fla, Tampa, an All Children's Hospital, St. Petersburg, Florida.
Vitamin D3 is hydroxylated in the liver (C-25) and then in th kidney (C-1) to produce 1,25(OH)2D3. To study pituitary influenc upon this sequence, intact (I) or hypophysectomized (H) 30 day male rats were maintained on a Vitamin D-deficient diet for 28 days. During the last 14 days, daily s.c. injections of diluent were given to I and H; other H received 2 mg bovine GH or prolactin (Prl). 12 h prior to the last injection, radiolabeled D3 or 250HD3 was injected i.p. and 26 h later the animals were sacrificed. After extraction, the radiolabeled metabolites in plasma, small intestine and bone were separated on Sephadex LH-2 colunms. The % radioactivity as 250HD was higher in serum of I (25%) than in H (lo%), and GH treatment restored levels to norma (20%).
A similar pattern was seen in small intestine and bone. % radioactivity as 1,25(OH)2D3 was higher in 1 in intestine(27X) bone (15%) and plasma (12%) than in H (2.7, 1, 1.3%) and increased in H after GH treatment (9.6, 5.2, 2.3%). In I maintaine on a D-adequate diet for 4 weeks, serum 250HD (23.9?5.5(SD)ng/ml was hi her than in H (12.3i3.2.p c.01).
Prl had no effect upon serum 5H-250HD3, but partially restored levels in intestine and bone; Prl did not affect la-hydroxylation. Conclusions: 1) The anterior pituitary is important for 25-and la-hydroxylation of Vitamin D; 2) GH and possibly Prl stimulate hepatic 25-hydroxylase activity; 3) GH enhances renal la-hydroxylation; 4) GH may be a regulator of calcium homeostasis through these mechanisms. A lack of glucocorticoids causes fasting hypoglycemia. This is usually ascribed to impaired gluconeogenesis from protein. We examined the metabolic response of adrenalectomized (adrenx)rats to fasting.
AT-CARBOHYDRATE INTERRELATIONSHIPS
Adrenx rats (n=32; confirmed by corticosterone assay), after reatabilization, were fasted for 48 hours. They exhibited lower levels of glucose (55.2f 3.3 vs. 66.52 3.5 mgldl, mean * SEM; p 40.025), free fatty acids (FFA) (781-1 38 vs. lOlOf 44,uEqll; p 40.001) and ketones (2.4f 0.24 vs. 5.56k 0.33 mM; pC0.001)than sham-operated controls (n=27).
Intramuscular cortisone acetate (0.5 mglday) raised the fasting levels of FFA (83M 85), ketones (3.46f 0.65) and glucose (69.7f 4.0).The urinary excretion of urea nitrogen in the adrenx rats exceeded that of controls (263.2f 14.3 vs. 166.7-1 14.0 mgl 48 hours; pL0.001), and was not increased by the glucocorticoid therapy (253.3f 14.7).
Clearly, glucocorticoids did not raise the glucose in the adrenx rats by enhancing gluconeogenesis from protein.
FFA and ketones are major fuels of fasting. A lack would increase glucose oxidation and predispose to hypoglycemia.
We conclude that glucocorticoids do not sustain fasting levels of glucose by enhancing gluconeogenesis from protein but by reducing the consumption of glucose through greater availahilitv and tltiliratinn nf f n l r l c r t r r i~r o . in newborns by an impairment & ~luconeogenesis suggests t h a t the high incidence of hypoglycemia (hypogly) in SGA neonates may r e f l e c t the extent of fasting imposed on them by nursery feeding practice. To evaluate the effect of early feeding on plasma glucose (glu) levels, 18 healthy SGA infants ( 1 0 % i l e , 35-41 wk gest) were nipple-fed a t 3 hour (hr) intervals starting within 2 hrs a f t e r delivery. Glu was measured before each feeding f o r the f i r s t 25 hrs of l i f e . 11 healthy SGA infants in whom feedings were routinely withheld u n t i l 8 hrs of age served a s controls. Mean ( i s m ) glu prior t o feed #1 was 59+7mg/dl anl then ranged between 63f4 and 73+5mg/dl. None of the 143 glu values was < 35mg/dl. Only 3/18 (17%) early fed infants had a glu < 40mg/dl ( a l l prior t o feed #I) vs 8/11 (73%) control infants (p=.02). After the f i r s t feed, none of the early fed infants had a glu < 4Gmg/dl.
These data indicate that glu i s maintained in SGA infants a t higher levels in response t o early feedings. The current definition of hypogly in SGA infants (glu ( 25mg/dl) , based on surveys of glu when feedings were routinely withheld for 24-72 hrs a f t e r b i r t h , may underestimate the level of glu which i s physiologically normal for these infants. The present study suggests that it i s reasonable t o r a i s e the level of glu used t o define hypogly in SGA neonates t o that used in older children (4Gmg/dl) Depts. of Peds., USE College of Medicine, Tampa, and Univ. of Colorado Medical Center, Denver.
Serum concentrations of 24,25(OH)2D, a metabolite of Vitamin D synthesized mainly by renal 250HD-24 hydroxylase, and of 250HI were measured in normal and uremic subjects by competitive protein binding radioassay after isolation by Sephadex LH-20 chromatography. The mean (iSE) concentration of 24,25(OH)2D in 10 hemodialyzed children (H) (creatinine clearance(CrC1) < 5ml/min/ 1.73~~2) was significantly (P <01) lower (.87+.13ng/ml) than in 12 normal children (2.98t.45). Mean serum 24,25(OH)2D in 10 azotemic children not requiring hemodialysis (CrC1>5-100) was also lower (1.30i.12, p<Ol) than in normal children, but highel (p <05) than in H. Mean radioassayable 250HD concentrations were similar in all groups. Serum 24,25(OH)2D levels and 24,25(OH)2D/250HD ratios correlated significantly with CrCl (r= .62, p<Ol and r=.76, p<01, respectively) when all subjects were analyzed. In a group of 6 anephric adults, serum 24,25(OH)2D levels (.55+. 20) were lower (p < 01) than in 18 normal adults (1.70i.15) and undetectable in 3. Conclusions: (1) Compromised renal function is associated with dccreased serum 24,25(OH)zD, an easily measured vitamin D metabolite; (2) 250HD levels do not differ from normal in patients with renal insuffiency; 3) Diminished 24,25(OH)2D values may parallel renal 1-hydroxylase activity which is also decreased in uremia; ( 4 ) Lowered 1,25(OH)2D and 24,25(OH)2D production may both contribute to the development of renal osteodystrophy.
